Key facts
- Varian Medical Systems’s last known valuation is $16.4B (Apr 2021).
- Notable investors include UPMC Enterprises, Accelmed.
- Status: Acquired/Merged (Operating Subsidiary).
Investors
2- ·The complete investor list — 2 names
- ·Watchlist + deal alerts for Varian Medical Systems
- ·The full record, as it builds
Funding rounds
No funding rounds for Varian Medical Systems are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Varian Medical Systems
Developer of radiation therapy equipment and oncology information systems designed to support cancer diagnosis and treatment. The company offers devices for targeted radiation delivery, imaging, and treatment planning software, enabling healthcare providers and cancer centers to enhance clinical precision, streamline workflows, manage patient data, and improve outcomes for individuals receiving cancer care.
- Sector
- Healthcare
- HQ
- Palo Alto, CA, United States
- Founded
- 1948
- Employees
- 9,914
- Website
- varian.com/
- Ownership
- Acquired/Merged (Operating Subsidiary)
Varian Medical Systems doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Varian Medical Systems shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Varian Medical Systems in its N-PORT filings yet. We sweep new filings monthly.